|
| |
 |
|
India has become a favored destination for pivotal as well as early stage Proof of Concept (PoC) studies. TMI was formed in 2004 in order to make available to western clinical researchers the tremendous advantages of conducting early stage clinical research in India.
In an industry facing increasing pressures, where most products in development fail, the greatest tragedy is to have a product that works but a clinical trial that fails to show it. TMI works closely with clients on trial design and implementation to bring the multiple advantages of India to their early clinical development programs.
Many pivotal trials are expanding outside western boundaries with India a prime destination. However, western clients are increasingly realizing that exporting the western CRO model does not necessarily work in India and regional factors have to be taken into account while ensuring global quality standards are implemented. TMI has an impressive track record of helping clients achieve their goals on pivotal trials – TMI managed sites are often the best performing globally.
TMI is a US based corporation, with operations headquartered in Bangalore, India and offices in numerous Indian cities. |
| |
|
|
|
